Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01560988 · ClinicalTrials.gov registry record · Phase 3
Borage and Echium Seed Oils for Asthma
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 62
- Enrollment target
NCT01560988 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 62 participants.
The verdict
NCT01560988, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 62 participants
- Enrollment target
Study Summary
This study plans to look at whether borage and echium seed oils (natural oils from two plants) help decrease asthma symptoms and affect cells involved in inflammation. The investigators also want to look at how these plant oils decrease the generation of inflammatory cells in people with asthma.
Interventions
- DRUG Borage and Echium Seed Oils
- DIETARY_SUPPLEMENT Corn oil pills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01560988
The ClinicalTrials.gov registry entry for NCT01560988 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Borage and Echium Seed Oils is the first listed.
NCT01560988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01560988 about?
NCT01560988 is a clinical study titled "Borage and Echium Seed Oils for Asthma". This study plans to look at whether borage and echium seed oils (natural oils from two plants) help decrease asthma symptoms and affect cells involved in inflammation. The investigators also want to look at how these plant oils decrease the generation of inflammatory cells in people with asthma.
What is the current status of trial NCT01560988?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 62 participants. The study started on 2013-02. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01560988?
The interventions under investigation include: Borage and Echium Seed Oils (DRUG), Corn oil pills (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01560988?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.